Biocon's Shaw Reckons Rivals' China Reliance Gives It the Edge in GLP-1 Race
In an exclusive interview to NDTV Profit, Biocon founder, Kiran Mazumdar-Shaw, also said that insulin "will never go away" and defended company's low-margin bet. from NDTV Profit - Latest https://ift.tt/fYHBPEq In an exclusive interview to NDTV Profit, Biocon founder, Kiran Mazumdar-Shaw, also said that insulin "will never go away" and defended company's low-margin bet.